Analysis of HIV‐1 mutation patterns in patients failing antiretroviral therapy

The emergence of mutations encoding drug resistance is supposed to be a significant limitation to the clinical efficacy of inhibitor compounds directed against specific HIV‐1 enzymatic targets. We have used a commercial test (Visible Genetics Inc., Paris, France) to study the prevalence of mutations...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Lab Anal
Auteurs principaux: Quiros‐Roldan, Eugenia, Signorini, Simona, Castelli, Francesco, Torti, Carlo, Patroni, Andrea, Airoldi, Monica, Carosi, Giampiero
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2001
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6807694/
https://ncbi.nlm.nih.gov/pubmed/11170234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1098-2825(2001)15:1<43::AID-JCLA9>3.0.CO;2-I
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires